Sign In

Jennifer Lam, PhD, MPH

People

Kaiser Permanente Division of Research
2000 Broadway
Oakland, CA 94612

(510) 891-3438 (phone)
Jennifer.O.Lam@kp.org


Jennifer Lam, PhD, MPH, is a Postdoctoral Research Fellow at the Kaiser Permanente Northern California Division of Research. She received her bachelor's in English from the University of California, Berkeley, and both her master's in Public Health and doctorate in Epidemiology and International Health from Johns Hopkins University.

Dr. Lam has a background in the surveillance and epidemiology of infectious diseases, with a focus on HIV, HPV, and vaccine-preventable diseases. Her current research interests include evaluations of substance use, aging-related conditions, and cancer in populations with HIV.

Current Position(s):

  • Postdoctoral Research Fellow, Division of Research, Kaiser Permanente Northern California

Section Affiliations:

Primary Research Interests:

  • HIV and aging
  • Infection-associated cancers
  • Infectious disease epidemiology

    Neurocognitive Impairment and Dementia in People With and Without HIV

    People with HIV are at increased risk for dementia due to the combined effects of HIV-associated inflammation and traditional (non-HIV) risk factors such as chronic drug use and cerebrovascular disease. With the widespread use of antiretroviral therapy for the treatment of HIV infection, severe forms of HIV-associated dementia are now uncommon, but milder forms of neurocognitive impairment remain a persistent concern, potentially affecting up to 50% of people living with HIV. In preparation for future investigations on cognitive dysfunction in people aging with HIV, we are conducting a study to establish baseline knowledge on: 1) The prevalence of neurocognitive impairment and dementia, and 2) Risk factors for neurocognitive disorders among Kaiser Permanente Northern California patients with HIV compared to patients without HIV.
    Investigator: Lam, Jennifer
    Funder: Northern California Community Benefit Programs
    No results found matching criteria

    Colorectal Cancer Screening in People With and Without HIV in an Integrated Health Care Setting

    Author(s): Lam JO; Hurley LB; Udaltsova N; Alexeeff SE; Klein DB; Corley DA; Silverberg MJ

    J Acquir Immune Defic Syndr. 2019 Jul 01;81(3):284-291.

    PubMed abstract

    Interventions to Reduce Unhealthy Alcohol Use among Primary Care Patients with HIV: the Health and Motivation Randomized Clinical Trial

    Author(s): Satre DD; Leibowitz AS; Leyden W; Lam JO; Weisner CM; Sterling SA; Silverberg MJ; et al.

    J Gen Intern Med. 2019 Jun 11.

    PubMed abstract

    Hepatitis C treatment uptake and response among human immunodeficiency virus/hepatitis C virus-coinfected patients in a large integrated healthcare system.

    Author(s): Lam, Jennifer O JO; Hurley, Leo B LB; Chamberland, Scott S; Champsi, Jamila H JH; Gittleman, Laura C LC; Korn, Daniel G DG; Lai, Jennifer B JB; Quesenberry, Charles P CP; Ready, Joanna J; Saxena, Varun V; Seo, Suk I SI; Witt, David J DJ; Silverberg, Michael J MJ; Marcus, Julia L JL

    International journal of STD & AIDS. 2019 Jun ;30(7):689-695. Epub 2019-05-02.

    PubMed abstract

    Early outcomes of a high-resolution anoscopy-based anal cancer screening program among people with HIV enrolled in an integrated healthcare system

    Author(s): Barnell GM; Merchant M; Lam JO; Silverberg MJ

    J Acquir Immune Defic Syndr. 2019 Mar 29.

    PubMed abstract

    Effectiveness of catch-up human papillomavirus vaccination on incident cervical neoplasia in a US health-care setting: a population-based case-control study

    Author(s): Silverberg MJ; Leyden WA; Lam JO; Gregorich SE; Huchko MJ; Kulasingam S; Kuppermann M; Smith-McCune KK; Sawaya GF

    Lancet Child Adolesc Health. 2018 Oct;2(10):707-714. Epub 2018-08-08.

    PubMed abstract

    Acceptability of high-resolution anoscopy for anal cancer screening in HIV-infected patients

    Author(s): Lam JO; Barnell GM; Merchant M; Ellis CG; Silverberg MJ

    HIV Med. 2018 Aug 06.

    PubMed abstract

    Disparities in Initiation of Direct-Acting Antiviral Agents for Hepatitis C Virus Infection in an Insured Population.

    Author(s): Marcus JL; Lam JO; Quesenberry CP; Silverberg MJ; et al.

    Public health reports (Washington, D.C. : 1974). 2018 Jan 01;():33354918772059. Epub 2018-01-01.

    PubMed abstract